EnCompass Technologies

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, EnCompass Technologies sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

EnCompass Technologies: 1 sponsored US clinical trial, 1 recruiting.

EnCompass Technologies sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Aortic Stenosis Treated With TAVI, with 1 trials.

Mid-pack sponsor footprint

EnCompass Technologies is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NCT06689839

Therapeutic Areas

Aortic Stenosis Treated With TAVI 1
Aortic Diseases 1

What is open in the EnCompass Technologies pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Aortic Stenosis Treated With TAVI (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

EnCompass Technologies: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

EnCompass Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share EnCompass Technologies1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
EnCompass Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

EnCompass Technologies sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this EnCompass Technologies page

1 registered trials is a research-attention snapshot, not an endorsement of EnCompass Technologies or any single study.

  • 1 of EnCompass Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aortic Stenosis Treated With TAVI is the condition EnCompass Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Stenosis Treated With TAVI trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

EnCompass Technologies pipeline card: 1 registered trials from official public datasets.Report a data error.